Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Plavix recommended for use in new PAD guidelines

Dec. 19, 2005

Roche and Maxygen to codevelop recombinant factor VIIa products

Dec. 19, 2005

SPA agreement for phase III study of alfimeprase in peripheral arterial occlusion

Dec. 16, 2005

Phase III ACUITY study of Angiomax completes enrollment

Dec. 13, 2005

New inhibitor of factor VIIa prevents tissue factor-initiated thrombus formation

Dec. 13, 2005

Ono and Dainippon Sumitomo sign new agreement for limaprost alfadex

Dec. 13, 2005

Recent patents report new treatments for thrombotic disorders

Dec. 7, 2005

Results from the ANTHEM-TIMI 32 trial of rNAPc2 presented

Nov. 29, 2005

GlaxoSmithKline seeks Japanese approval for fondaparinux sodium

Nov. 25, 2005

Recent Merck KGaA patent claims novel anticoagulant agents

Nov. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....